Cancer

Items 1561-1570 of 2218

per page
Set Descending Direction
  1. Jagged-2 (human):Fc (human) (rec.)
    AG-40A-0155Y
    AG-40A-0155Y-C01010 µg
    CHF 265.00
  2. Jak/Src Inhibitor 1 . hydrochloride
    CAS  1332329-27-7 (parent)
    AG-CR1-3647
    AG-CR1-3647-M0011 mg
    CHF 150.00
    Jak/Src Inhibitor 1 . hydrochloride
  3. Jasplakinolide (high purity)
    CAS  102396-24-7
    AG-CN2-0037
    AG-CN2-0037-C05050 µg
    CHF 260.00
    AG-CN2-0037-C100100 µg
    CHF 420.00
    Jasplakinolide (high purity)
  4. JC-1
    CAS  3520-43-2 and 47729-63-5
    AG-CR1-3568
    AG-CR1-3568-M0011 mg
    CHF 80.00
    AG-CR1-3568-M0055 mg
    CHF 230.00
    AG-CR1-3568-50015 x 1 mg
    CHF 320.00
    JC-1
  5. JC-10 (high purity)
    AG-CR1-3600
    AG-CR1-3600-M0011 mg
    CHF 80.00
    AG-CR1-3600-M0055 mg
    CHF 240.00
    JC-10 (high purity)
  6. JNJ-38158471
    CAS  951151-97-6
    SYN-1133
    SYN-1133-M0011 mg
    CHF 270.00
    SYN-1133-M0055 mg
    CHF 546.00
    SYN-1133-M01010 mg
    CHF 766.00
    SYN-1133-M05050 mgINQ
    SYN-1133-M100100 mgINQ
    JNJ-38158471
  7. JNJ-38877605
    CAS  943540-75-8
    SYN-1047
    SYN-1047-M0011 mg
    CHF 128.00
    SYN-1047-M0055 mg
    CHF 184.00
    SYN-1047-M01010 mg
    CHF 298.00
    SYN-1047-M05050 mg
    CHF 1'064.00
    SYN-1047-M100100 mgINQ
    JNJ-38877605
  8. JNJ-7706621
    CAS  443797-96-4
    SYN-1048
    SYN-1048-M0011 mg
    CHF 177.00
    SYN-1048-M0055 mg
    CHF 298.00
    SYN-1048-M01010 mg
    CHF 504.00
    SYN-1048-M05050 mg
    CHF 1'185.00
    SYN-1048-M100100 mgINQ
    JNJ-7706621
  9. Josamycin
    CAS  16846-24-5
    CDX-J0001
    CDX-J0001-M05050 mg
    CHF 52.00
    CDX-J0001-M200200 mg
    CHF 157.00
    CDX-J0001-GG252.5 g
    CHF 976.00
    Josamycin
  10. K-252a
    CAS  99533-80-9
    AG-CN2-0019
    AG-CN2-0019-C100100 µg
    CHF 80.00
    AG-CN2-0019-M0011 mg
    CHF 210.00
    K-252a

Items 1561-1570 of 2218

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.